TSX-V Symbol "ERG"
MONTREAL, May 30 /CNW Telbec/ - Ergoresearch Ltee "Ergoresearch" (TSX-V: ERG) is proud to announce record high sales for a third quarter. Sales reach $483 863 for the third quarter, up 35% from the same quarter last year. These results are primarily due to the company's marketing efforts which led to internal growth from its retail division, Clinique du Pied Equilibre (fully owned subsidiary). Profit after 3 quarters are reaching $29 182.
"Above and beyond current results, it is also Ergoresearch's increasing capacity that makes for a promising future." said Sylvain Boucher, president and CEO of Ergoresearch.
----------
Ergoresearch Ltd. is a holding company and through its subsidiaries, a leading Canadian manufacturer of orthotics and a state-of-the-art designer of durable medical equipment for the orthopedics market. The company, now vertically integrated has the ambition of becoming an international leader in the orthopedic industry.
----------
This document contains prospective statements based on current expectations, forecasts and assumptions. These statements involve risk and uncertainty factors that could influence actual results. These factors include, among other things: market fluctuations, competition, availability of specialized labor, and technological developments.
----------
THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT
RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
%SEDAR: 00016933EF